Anti-IBPL1/ IGFBPL1/ IGFBP-RP4 functional antibody

Anti-IBPL1/ IGFBPL1/ IGFBP-RP4 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to IGFBPL1/IGFBPL1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0988-Ab-1/ GM-Tg-hg-SE0988-Ab-2Anti-Human IGFBPL1 monoclonal antibodyHuman
GM-Tg-rg-SE0988-Ab-1/ GM-Tg-rg-SE0988-Ab-2Anti-Rat IGFBPL1 monoclonal antibodyRat
GM-Tg-mg-SE0988-Ab-1/ GM-Tg-mg-SE0988-Ab-2Anti-Mouse IGFBPL1 monoclonal antibodyMouse
GM-Tg-cynog-SE0988-Ab-1/ GM-Tg-cynog-SE0988-Ab-2Anti-Cynomolgus/ Rhesus macaque IGFBPL1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0988-Ab-1/ GM-Tg-felg-SE0988-Ab-2Anti-Feline IGFBPL1 monoclonal antibodyFeline
GM-Tg-cang-SE0988-Ab-1/ GM-Tg-cang-SE0988-Ab-2Anti-Canine IGFBPL1 monoclonal antibodyCanine
GM-Tg-bovg-SE0988-Ab-1/ GM-Tg-bovg-SE0988-Ab-2Anti-Bovine IGFBPL1 monoclonal antibodyBovine
GM-Tg-equg-SE0988-Ab-1/ GM-Tg-equg-SE0988-Ab-2Anti-Equine IGFBPL1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0988-Ab-1/ GM-Tg-hg-SE0988-Ab-2; GM-Tg-rg-SE0988-Ab-1/ GM-Tg-rg-SE0988-Ab-2;
GM-Tg-mg-SE0988-Ab-1/ GM-Tg-mg-SE0988-Ab-2; GM-Tg-cynog-SE0988-Ab-1/ GM-Tg-cynog-SE0988-Ab-2;
GM-Tg-felg-SE0988-Ab-1/ GM-Tg-felg-SE0988-Ab-2; GM-Tg-cang-SE0988-Ab-1/ GM-Tg-cang-SE0988-Ab-2;
GM-Tg-bovg-SE0988-Ab-1/ GM-Tg-bovg-SE0988-Ab-2; GM-Tg-equg-SE0988-Ab-1/ GM-Tg-equg-SE0988-Ab-2
Products NameAnti-IGFBPL1 monoclonal antibody
Formatmab
Target NameIGFBPL1
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-IGFBPL1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0988-Ag-1Recombinant multi-species IBPL1/ IGFBPL1/ IGFBP-RP4 protein
    CytokineGM-Tg-g-SE0988-Ag-1insulin-like growth factor binding protein-like 1 (IGFBPL1) protein


    Target information

    Target IDGM-SE0988
    Target NameIGFBPL1
    Gene ID347252,75426,366366,100425543,481621,101091055,616886,100630374
    Gene Symbol and Synonyms2810011G06Rik,2810453O06Rik,bA113O24.1,IGFBP-RP4,IGFBPL,IGFBPL1,IGFBPRP4
    Uniprot AccessionQ8WX77,A5PKD8
    Uniprot Entry NameIBPL1_HUMAN,IBPL1_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryCytokine Target
    DiseasePregnant state
    Gene EnsemblENSG00000137142
    Target ClassificationN/A

    The target: IGFBPL1, gene name: IGFBPL1, also named as IGFBP-RP4, IGFBPRP4, bA113O24.1. Predicted to enable insulin-like growth factor binding activity. Involved in cellular response to tumor cell. Located in extracellular space. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.